Stereochemistry and enantiomeric purity of a novel anxiolytic agent, deramciclane fumarate

The synthesis, stereostructure, and enantiomeric separation by chromatography of a new, chiral anxiolytic agent, deramciclane fumarate (2, (−)‐[1R,2S,4R]‐2‐(2‐dimethylaminoethoxy)‐2‐phenyl‐1,7,7‐trimethylbicyclo[2.2.1]heptane fumarate, EGIS‐3886), is described. The optical antipode and the racemate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chirality (New York, N.Y.) N.Y.), 1999, Vol.11 (9), p.689-693
Hauptverfasser: Ladányi, László, Sztruhár, Ilona, Budai, Zoltán, Lukács, Gyula, Mezei, Tibor, Argay, Gyula, Kálmán, Alajos, Simig, Gyula
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The synthesis, stereostructure, and enantiomeric separation by chromatography of a new, chiral anxiolytic agent, deramciclane fumarate (2, (−)‐[1R,2S,4R]‐2‐(2‐dimethylaminoethoxy)‐2‐phenyl‐1,7,7‐trimethylbicyclo[2.2.1]heptane fumarate, EGIS‐3886), is described. The optical antipode and the racemate of compound 2 were also prepared. The structure was determined by single crystal X‐ray diffraction analysis. The enantiomeric separation was accomplished by HPLC on Chiralcel OD (250 × 4.6 mm; 10 μm) and hexane‐ethanol (99.5:0.5) as mobile phase at room temperature. The enantiomeric purity of the synthesized drug substance proved to be very high (>99.9%). Some statements published earlier on the stereostructure of deramciclane fumarate are critically discussed. Chirality 11:689–693, 1999. © 1999 Wiley‐Liss, Inc.
ISSN:0899-0042
1520-636X
DOI:10.1002/(SICI)1520-636X(1999)11:9<689::AID-CHIR4>3.0.CO;2-X